Monoclonal antibody (phase I)

Owner Name: Guangzhou Biotech Biopharmaceutical Co., Ltd.
Project Amount: 35 million RMB
Project Contents: Medium Configuration/CIP/Buffer Configuration/Storage Tank/Purification/Receipt (Pipe Valve & Tank & Control System)
Production Method: Factory Module Assembly, FAT, Module Docking
Project Introduction
Media Preparation System Feeding System for 2x3000 Liter Bioreactor Provided by Bilfinger
Harvesting System
Buffer Preparation and Retention System Chromatograph 1, 2, 3 Systems Product Inactivation System 4 sets of CIP, waste killing system
15 Process slippage, including 50 containers from 250 liters to 15,000 liters Siemens PCS7 and ISA88 principle-based formulation control and management system
Complies with US FDA and European cGMP standards